Mobile

Safety, Tolerability and Pharmacokinetics of 3 Dose regimens of AZD1446 vs. Placebo as an Add-on Treatment to Donepezil: A Multi-centre, Double-blind, Randomised, Placebo controlled, Parallel group Ph...

Update Il y a 4 ans
Reference: EUCTR2009-015525-37

Safety, Tolerability and Pharmacokinetics of 3 Dose regimens of AZD1446 vs. Placebo as an Add-on Treatment to Donepezil: A Multi-centre, Double-blind, Randomised, Placebo controlled, Parallel group Phase IIa Study in Patients with Mild to Moderate Alzheimer’s Disease during 4 weeks of Treatment

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to evaluate the safety and tolerability of 3 dose regimens of AZD1446 compared to placebo as an add-on treatment to donepezil for 4 weeks in patients with mild to moderate Alzheimer’s disease (AD)

Inclusion criteria

  • Patients with mild to moderate Alzheimer's Desease

Links